FDA approves new dosing regimen for pembrolizumab
Food and Drug Administration granted accelerated approval to a new dosing regimen of 400 mg…
FDA
Convalescent Plasma: A Possible Treatment of COVID-19 in India
In India, SARS-CoV-2 virus-induced coronavirus disease 2019 (COVID-19) has already infected close to 31270 people,…
Conducting Clinical Trials During the COVID-19 Public Health Emergency
Reference: https://www.fda.gov/media/136238/download
FDA Reiterates Importance of Close Patient Supervision for ‘Off-Label’ Use of Antimalarial Drugs to Mitigate Known Risks, Including Heart Rhythm Problems
Today, the U.S. Food and Drug Administration issued a Drug Safety Communication regarding known side effects of…
Myths about Corona Virus.. Do you know this?
Here are few myths about corona virus which you should KNOW: Source: Google Images. Source:…
Covid-19: pandemic of 21st century.
Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. What is…
New Drug treatment for partial-onset seizures!
The U.S. Food and Drug Administration approved XCOPRI (cenobamate tablets) to treat partial-onset seizures in…
FDA approves second drug to prevent HIV infection(PrEP).
The U.S. Food and Drug Administration today approved Descovy (emtricitabine 200 mg and tenofovir alafenamide…
FDA awards two grants for natural history studies in rare diseases
The U.S. Food and Drug Administration today announced it has awarded two new research grants…
No Benefit Found for HbA1c Below 6.5% in Type 1 Diabetes .
A target HbA1c level of 6.5%-6.9% may be preferable to aiming below 6.5% in adults…